News
News 2006
 
January 2006 US award for social responsibility
In January 2006, Bayer receives the “Ron Brown Award for Corporate Leadership” of the U.S. President for its social commitment. It is the first company based outside the United States and the first company in the chemical industry to receive this award. The Ron Brown Award is the highest award in the United States for corporate social responsibility (CSR) programs, and is presented for the employee initiative “Making Science Make Sense,” with which Bayer has been supporting natural science education for school students for more than ten years.
 
January 2006 New Global Charter for Responsible Care
In January 2006, Bayer signs the Declaration of Support for the new “Global Charter Responsible Care.”
 
January 2006 Jump start for disadvantaged young people
In January 2006, our German “jump start” program for young people with learning difficulties is awarded the prize “Shaping Employment – Companies Demonstrate Responsibility” in the category “Prospects for Young People.” Bayer is the only DAX 30 company to receive this award, which is presented by the German Federal Ministry for Labor and Social Affairs and the Initiative for Employment. Back in November 2004, a German children’s charity honored Bayer for its exemplary commitment to socially disadvantaged young people.
 
January 2006 Possible risk with Trasylol®
In January 2006, reports from two different studies show a possible connection between Trasylol® (active ingredient: aprotinin) and severely impaired kidney function or vascular narrowing (heart attack and stroke). Studies performed over many years and Bayer’s own experience with Trasylol®, however, have shown it to be a safe and effective drug when used as directed. The present studies are currently being evaluated by the U.S. and European regulatory agencies (FDA and EMEA).
 
March 2006 Bayer and UNEP endorse partnership
Bayer and the United Nations Environment Programme (UNEP) endorse their collaboration in global youth environmental activities. Bayer Management Board Chairman Werner Wenning and the then UNEP Executive Director Professor Klaus Töpfer give a positive rating to their first two years of partnership in the area of youth and the environment at a press conference in mid-March 2006 in Leverkusen.

In June 2004, Bayer and UNEP concluded a cooperation agreement with an initial duration of three years that globalized the two parties’ previous collaboration in Asia. Since that time, Bayer has helped the United Nations Environment Programme to develop youth networks in Asia, Latin America and Africa, and to establish a global environment summit attended every two years by about 200 delegates from national youth environmental organizations.

Apart from that, Bayer and Tongji University, based in Shanghai, China, sign a memorandum of understanding concerning the establishment of a Chair for Sustainable Development. In addition, the two cooperation partners inaugurate an “Endowed Chair for Intellectual Property Rights” at the beginning of April 2006 in Shanghai.
 
April 2006 Schering acquisition
In April 2006, Bayer submits a public offer to acquire Schering AG. The Berlin company and the present pharmaceuticals business of Bayer are to be merged into an independent division of the Bayer HealthCare subgroup with the name “Bayer-Schering-Pharma.” In June 2006 the way is cleared for the Bayer Group to acquire Schering AG when Bayer gains control of a total of 88.0 percent of Schering’s some 191 million outstanding shares. The attainment of a three-quarters majority is the last remaining condition of the takeover offer. Both the European Commission and the U.S. antitrust authorities have already given their unconditional approval.
 
May 2006 Long-term aid for tsunami victims
More than a year after the devastating tsunami in south-east Asia, Bayer is still helping the victims. In May 2006, a medical and social center is dedicated in the south Indian village of Thenampattinam. It enables physicians to treat up to 200 people a day. Three other centers of this kind are to be opened in southern India in cooperation with other German companies. They will offer not only care for traumatized victims but also programs to promote the economic independence of women and children.
 
2006 Bitterfeld – A selected place in 2006
Aspirin® is one of the most famous brands in the world. It is less widely known that Bayer produces this pain reliever at its Bitterfeld site in Saxony-Anhalt. The tablet factory is one the “Selected Places 2006” identified by the “Germany – Land of Ideas” Initiative. A jury selected the Bayer location from more than 1,200 submitted entries as one of 365 outstanding places in the context of “Land of Ideas,” a joint initiative organized by the federal government and German companies, among them Bayer AG. The campaign is publicizing the innovative power of Germany to tie in with the soccer World Cup which is being hosted there in 2006.
top
Search
Search
Additional Info Links
Enter the relevant code given in the printed version of the Sustainable Development Report
 
Service
 
Dialogue
zoom - normal view 100% zoom + Textversion